SERPINB1 and schizophrenia: Postmortem studies, CSF assessment and in vivo imaging studies also suggested that patients with schizophrenia had altered concentrations of GABA and glutamate, which indicated an alteration in E-I signaling at levels of individual synapses, circuits and networks.